Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus

Eur J Pharmacol. 1998 May 8;348(2-3):155-60. doi: 10.1016/s0014-2999(98)00150-2.

Abstract

These experiments tested the hypothesis that substance P neurotransmission at tachykinin NK1 receptors in the locus coeruleus is involved in stress-induced activation of the locus coeruleus, using c-fos as an index of activation. Selective tachykinin NK1 receptor antagonists administered systemically did not result in substantial locus coeruleus c-fos expression. Restraint stress resulted in a large number of locus coeruleus c-fos expressing cells. Administration of two selective tachykinin NK1 receptor antagonists prior to restraint resulted in an increase in the number of locus coeruleus c-fos expressing cells, compared to restraint alone. These results suggest that the enhanced c-fos expression observed in response to tachykinin NK1 receptor antagonists combined with stress, could be due to the blockade of tachykinin NK1 receptor-mediated activity at sites other than the locus coeruleus, resulting in an overall activation of the locus coeruleus.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetamides / pharmacology
  • Analgesics / pharmacology
  • Animals
  • Gene Expression Regulation / drug effects
  • Genes, fos / drug effects*
  • Indoles / pharmacology
  • Isoindoles
  • Locus Coeruleus / drug effects*
  • Locus Coeruleus / metabolism
  • Neurokinin-1 Receptor Antagonists*
  • Piperidines / pharmacology
  • Quinuclidines / pharmacology
  • Rats
  • Restraint, Physical
  • Stereoisomerism
  • Stress, Physiological / etiology
  • Stress, Physiological / metabolism*
  • Substance P / metabolism
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / genetics

Substances

  • Acetamides
  • Analgesics
  • Indoles
  • Isoindoles
  • LY 306740
  • Neurokinin-1 Receptor Antagonists
  • Piperidines
  • Quinuclidines
  • 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one
  • SR 140333
  • Substance P